NCT06491030

Brief Summary

Proximal junctional kyphosis (PJK) is a common post-operative radiographic finding after surgery for adult spinal deformity (ASD) patients. Although the clinical relevance of isolated PJK is unclear, PJK can progress to symptomatic proximal junctional failures which requires a large revision surgery. Currently, post-operative bracing with a thoracolumbosacral orthosis (TLSO) is common practice after spinal deformity surgery, however the efficacy of this in preventing PJK is unknown. This multi-center randomized control trial identified 84 patients undergoing thoracolumbosacral fusion for ASD and plans to study the efficacy of a novel post-operative TLSO in preventing the development of PJK as defined by the proximal junctional angle on 6-month post-operative X-rays.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for phase_4

Timeline
7mo left

Started Dec 2024

Geographic Reach
1 country

6 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress72%
Dec 2024Dec 2026

First Submitted

Initial submission to the registry

June 20, 2024

Completed
18 days until next milestone

First Posted

Study publicly available on registry

July 8, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

December 2, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

February 13, 2026

Status Verified

January 1, 2026

Enrollment Period

2 years

First QC Date

June 20, 2024

Last Update Submit

February 11, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • The incidence of proximal junctional kyphosis development

    As defined by a proximal junctional angle both ≥10° and 10°greater than pre-operative values.

    This will be measured via scoliosis radiographs at the pre discharge, 6-week, and 6-month time points.

Secondary Outcomes (2)

  • Change in patient reported outcome measures

    6 week and 6-month time points

  • Change in patient reported outcome measures

    6 week and 6-month time points

Study Arms (2)

Thoracolumosacral Orthosis

EXPERIMENTAL

Patients randomized to this arm will be fitted with an Aspen Medical Products "Align PJK™" TLSO brace. This is a 3-point, rigid hyperextension TLSO brace which is currently FDA approved under a 510k exemption but not commercially available. With this brace, the sternal pad height/width and belt component will be adjusted to optimize patient position and comfort. The brace will also be fitted with an external temperature sensing probe. Patients will be instructed to wear the brace at all times, including when in bed for 6-weeks post-operatively. At the 6-week visit patients will be asked to self-report compliance with the brace

Device: Align PJK™ TLSO brace

No brace

PLACEBO COMPARATOR

Patients in the control arm will be treated without a brace but will have no other differences in their post-operative treatment protocol. This will be considered "usual care" for the purposes of this study.

Other: Standard of Care

Interventions

Patients will get randomized to receiving and wearing a back brace for 6 weeks postoperatively.

Thoracolumosacral Orthosis

Patients will receive the standard of care postoperative instructions without a brace

No brace

Eligibility Criteria

Age30 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years-old
  • Undergoing primary thoracolumbosacral fusion for ASD with an upper instrumented vertebrae (UIV) between T8-L2 and lower instrumented vertebrae (LIV) of S1 or the ilium.

You may not qualify if:

  • Osteoporosis (defined as a T-score \<-2.5 at the time of surgery)
  • Body mass index (BMI) \>35 kg/m2
  • Revision fusions
  • Fusions for trauma
  • Those with a neuromuscular etiology for their deformity (i.e. Parkinson's disease, cerebral palsy, post-stroke, etc.)
  • An underlying inflammatory arthropathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Indiana Spine Group

Carmel, Indiana, 46032, United States

ACTIVE NOT RECRUITING

University of Kansas

Overland Park, Kansas, 66211, United States

ACTIVE NOT RECRUITING

Hospital for Special Surgery

New York, New York, 10021, United States

RECRUITING

University of Texas Health, Houston

Bellaire, Texas, 77401, United States

ACTIVE NOT RECRUITING

Texas Back Institute

Dallas, Texas, 75243, United States

ACTIVE NOT RECRUITING

Virgina Mason Franciscan Health

Seattle, Washington, 98101, United States

ACTIVE NOT RECRUITING

MeSH Terms

Interventions

Standard of Care

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 20, 2024

First Posted

July 8, 2024

Study Start

December 2, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

February 13, 2026

Record last verified: 2026-01

Locations